Implicity, a leader in remote patient monitoring and cardiac data management solutions, today revealed new research presented at the 2026 European Heart Rhythm Association Congress (EHRA) examining ...

Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...

Once submitted, the ECG is evaluated within 24 hours by a Canadian-registered cardiologist from WELL Health's network. Each review provides a more comprehensive clinical evaluation to confirm or ...

Artificial intelligence (AI)-based algorithms that use electrocardiogram (ECG) data have high accuracy in predicting ST-elevation myocardial infarction (STEMI), according to study ...

Data presented at ACC.26 demonstrate a high prevalence of clinically actionable arrhythmias across CKM patient populations using the Zio® ...

Identification of systolic heart failure among patients presenting to the emergency department (ED) with acute dyspnea is challenging. The reasons for dyspnea are often multifactorial. A focused ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized ...

Real-world evidence to be presented at the American College of Cardiology Scientific Session 2026 highlights impact of Viz HCM, developed as part of a multi-year agreement with Bristol Myers Squibb, ...

Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive myocardial infarction (MI), according to a study presented today at ESC Acute ...

HeartBeam's collaboration with Mount Sinai combines proprietary 3D ECG technology with clinical AI expertise to advance cardiac monitoring algorithms for remote patient care. HeartBeam announced a ...